TLRY Stock: Tilray's Aphria RX Receives Cannabis Trading License in Germany

TLRY stock also isn't seeing much movement today with a slight gain as of Monday afternoon. Tilray (NASDAQ:TLRY) stock is on the move Monday as investors in the cannabis company react to it securing a trading license in Germany for its Aphria RX subsidiary. Denise Faltischek, Chief Strategy Officer and Head of International at Tilray, said this about the news. Despite the additional license in Germany, TLRY stock isn't seeing much trading today. As of this writing, only about 12 million shares have changed ...